Workshops at Advanced Therapies Week

Take a look at the workshops we have taking place this year. If you would like to sign up to any, please do so via the form at the bottom of the page.

Wednesday January 17
A New Approach to CAR T Manufacturing: Gaining Control of T Cell Isolation and Activation to Promote Clinical Success

Brought to you by Thermo Fisher Scientific.

Wednesday, January 17, 2024, 8am – 9am. (Breakfast included)

A key factor that promotes positive clinical outcomes in cell therapy manufacturing is the achievement of a younger, less differentiated T cell population at the outset of the manufacturing process. In this talk, you will hear about new flexible solutions that increase control over target cell isolation and activation steps upstream in the process while simultaneously providing process flexibility for steps downstream. These new tools are designed to incorporate into a closed, scalable and automatable workflow, helping to streamline the process, with the potential to greatly reduce manufacturing timelines. This suite of modular instruments and tools spans the end-to-end workflow allowing the user greater flexibility and control of their process parameters to modulate the nuanced variables that affect end-point therapeutic efficacy.

Register your place via the form at the bottom of the page.

Thursday January 18
Anticipating the Unknowns: The Importance of Partnership and Optimizing Your Process

Brought to you by FUJIFILM Irvine Scientific.

Thursday, January 18, 2023, 8am – 9am. (Breakfast included)

  • Are you looking to speed up and scale out your cell therapy outcomes?
  • Do you have media development challenges that need to be improved?

In recent years, there has been a significant increase in Advanced Cell Therapies (ACT), which have the potential to transform the treatment of a number of diseases, such as cancer, genetic conditions, and degenerative diseases.

For the purposes of this panel review, we approaching these developments- and production-related challenges from a cell culture media perspective and highlighting its importance as a critical ancillary material throughout the development, manufacturing, and scale-up of ACTs.

Making the right decision the first time on in the process can help to save valuable time, money, and resources, especially when transitioning into the clinical trial phase and further scale-up.

Join us and our panel of experts as we discuss the challenges cell therapy developers have and solutions that can help speed time to market and remove bottlenecks before they happen.

Register your place via the form at the bottom of the page.

Interactive Workshop: Because Time Is Money – Manufacturing Strategies To Maximize Your Runway And Make It To Commercialization

Brought to you by Miltenyi.

Thursday, January 18, 2024, 2pm – 3pm.

In a more cautious economic landscape, it is more critical than ever to demonstrate a thorough and realistic plan to commercialization. This has to be balanced with the pressure to move quickly in an increasingly competitive space.

Join us for an interactive simulation, where you’ll work with your team to bring your asset to market:

Growing through all stages of clinical development, you’ll have to make choices around developing your process, whether to outsource, when to defer costs, how and when to build out capacity, and more.

Under real-world budget and time constraints, you’ll develop and execute your operating strategy, secure funding, and make tough trade-offs as you race other teams to be the first to market.

Come and enjoy some good food, meet new people, and engage in friendly competition and thought-provoking discussion.

And yes, there will be prizes.

Register your place via the form at the bottom of the page.

Deep Analytics, Reduced Cost & Fast Turnaround Times: Can You Have All 3?

Brought to you by Resilience.

Thursday, January 18, 2024, 2pm – 3pm.

Analytical development remains a critical component of the advanced therapies landscape, but lengthy production timelines and inherent complexity mean that improving analytical processes and expediting release times remain a key priority. With a variety of starting materials, manufacturing processes and assay technologies, how does one balance the need for deep biological insights without sacrificing precious turnaround times and commercially sustainable cost? Is there a method that can satisfy these 3 requirements for advanced therapy success?

Join us as we take a deep dive into the critical components of analytical development strategy, method development and innovative technologies that Resilience is developing aimed at optimizing release testing, meeting regulatory requirements, and impacting COGS. Our panel will share insights and innovations from our cutting-edge R&D team paving the way for advanced therapy analytics.

Register your place via the form at the bottom of the page.

Sign Up Here